Associated Papers
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants.
Stubbins RJ et al.
Leukemia, 2025
40335619 (PubMed )
Supplement: 41375_2025_2635_MOESM5_ESM.xls › CHEK2_Supplemental_Table_4_v25
c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?
Carvalho S et al.
Journal of Clinical Pathology, 2004
Select a paper to view details